CHICAGO--(BUSINESS WIRE)--Veradigm (NASDAQ: MDRX) announced today that Veradigm Network EHR Data is now available within the OMOP CDM format. Veradigm Network EHR is a complete statistically ...
Evaluating the cost-effectiveness of genetic testing in high-risk families with confirmed germline cancer mutations. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results